Burke & Herbert Bank & Trust Co. Raises Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Burke & Herbert Bank & Trust Co. increased its position in iShares Biotechnology ETF (NASDAQ:IBB) by 1.2% in the 4th quarter, Holdings Channel reports. The firm owned 8,809 shares of the financial services provider’s stock after buying an additional 105 shares during the period. Burke & Herbert Bank & Trust Co.’s holdings in iShares Biotechnology ETF were worth $1,165,000 as of its most recent filing with the SEC.

A number of other large investors have also recently made changes to their positions in the company. Darwin Wealth Management LLC acquired a new position in iShares Biotechnology ETF during the third quarter worth approximately $29,000. Highline Wealth Partners LLC purchased a new position in shares of iShares Biotechnology ETF during the third quarter worth approximately $30,000. HHM Wealth Advisors LLC increased its holdings in shares of iShares Biotechnology ETF by 200.0% in the 4th quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after acquiring an additional 150 shares during the period. Newbridge Financial Services Group Inc. purchased a new stake in iShares Biotechnology ETF in the 4th quarter valued at $33,000. Finally, Hager Investment Management Services LLC acquired a new stake in iShares Biotechnology ETF during the 4th quarter worth $34,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

Shares of iShares Biotechnology ETF stock opened at $136.55 on Monday. The company’s fifty day moving average is $135.73 and its two-hundred day moving average is $140.93. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were given a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.